Latest News

China manufacturing approvals expected to provide TruScreen greater market access. Local manufacturing contracts in China under negotiation with expected reduction in component costs. Novel Coronavirus…

"A novel diagnostic device for cervical cancer screening in India."

More cases of cervical cancer are diagnosed in China each year than in any other nation. China accounts for about 20 per cent of all…

Zimbabwe may be known for its pristine wilderness, but it is also a country facing a major public health crisis in the form of high…

TruScreen’s breakthrough cervical cancer screening device is a viable and attractive alternative to traditional cervical screening methods.

TruScreen is pleased to provide a copy of its November 2019 Stakeholder newsletter.

Cervical cancer affects millions of women worldwide. It is a silent killer, it has a high prevalence outside of developed countries, and almost all cases…

Cervical cancer is one of the most preventable and treatable forms of cancer1, yet over a quarter of a million women die from the disease…

Cervical cancer is the fourth most common cancer in women, with more than half a million women diagnosed with the disease in 20181. In low-…

TruScreen’s cervical cancer screening device demonstrates improved sensitivity and specificity targeting pre-cancerous and cancerous cervical cells